JPWO2020179797A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020179797A5 JPWO2020179797A5 JP2021504119A JP2021504119A JPWO2020179797A5 JP WO2020179797 A5 JPWO2020179797 A5 JP WO2020179797A5 JP 2021504119 A JP2021504119 A JP 2021504119A JP 2021504119 A JP2021504119 A JP 2021504119A JP WO2020179797 A5 JPWO2020179797 A5 JP WO2020179797A5
- Authority
- JP
- Japan
- Prior art keywords
- influenza
- split vaccine
- split
- producing
- vaccine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229960005486 vaccine Drugs 0.000 claims 37
- 206010022000 influenza Diseases 0.000 claims 34
- 238000004519 manufacturing process Methods 0.000 claims 18
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims 16
- 238000010306 acid treatment Methods 0.000 claims 9
- 239000007983 Tris buffer Substances 0.000 claims 2
- 239000007979 citrate buffer Substances 0.000 claims 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 claims 2
- 230000034217 membrane fusion Effects 0.000 claims 2
- 239000002953 phosphate buffered saline Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 2
- 241000712461 unidentified influenza virus Species 0.000 claims 2
- 206010069767 H1N1 influenza Diseases 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 201000010740 swine influenza Diseases 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019038662 | 2019-03-04 | ||
| JP2019038662 | 2019-03-04 | ||
| PCT/JP2020/008974 WO2020179797A1 (ja) | 2019-03-04 | 2020-03-03 | インフルエンザｈａスプリットワクチンの製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JPWO2020179797A1 JPWO2020179797A1 (enExample) | 2020-09-10 |
| JPWO2020179797A5 true JPWO2020179797A5 (enExample) | 2023-08-03 |
| JP7545955B2 JP7545955B2 (ja) | 2024-09-05 |
Family
ID=72337458
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021504119A Active JP7545955B2 (ja) | 2019-03-04 | 2020-03-03 | インフルエンザｈａスプリットワクチンの製造方法 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US12491240B2 (enExample) |
| EP (1) | EP3936147A4 (enExample) |
| JP (1) | JP7545955B2 (enExample) |
| KR (1) | KR20210135261A (enExample) |
| CN (1) | CN114096273A (enExample) |
| AU (1) | AU2020233456A1 (enExample) |
| BR (1) | BR112021017310A8 (enExample) |
| CA (1) | CA3132578A1 (enExample) |
| EA (1) | EA202192398A1 (enExample) |
| IL (1) | IL285984A (enExample) |
| MX (1) | MX2021010685A (enExample) |
| MY (1) | MY208974A (enExample) |
| PH (1) | PH12021552094A1 (enExample) |
| SG (1) | SG11202109566XA (enExample) |
| WO (1) | WO2020179797A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL280332B2 (en) | 2018-07-23 | 2025-05-01 | Japan As Represented By Director General Of Nat Institute Of Infectious Diseases | A preparation containing influenza vaccine |
| EP4054630A2 (en) * | 2019-11-07 | 2022-09-14 | Seqirus UK Limited | Compositions and methods for producing a viral vaccine with reduced particle size |
| WO2024225404A1 (ja) * | 2023-04-26 | 2024-10-31 | 国立感染症研究所長が代表する日本国 | 抗インフルエンザ抗体 |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2374894B1 (en) * | 1993-09-13 | 2014-09-17 | Protein Sciences Corporation | A method for producing influenza hemagglutinin multivalent vaccines |
| WO2008054481A2 (en) | 2006-03-24 | 2008-05-08 | Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, National Institutes Of Health | Improved inactivated influenza virus compositions |
| US20230201329A1 (en) * | 2006-07-17 | 2023-06-29 | Glaxosmithkline Biologicals Sa | Influenza vaccine |
| US20090181078A1 (en) * | 2006-09-26 | 2009-07-16 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| WO2008114819A1 (ja) | 2007-03-20 | 2008-09-25 | Dainippon Sumitomo Pharma Co., Ltd. | 新規アデニン化合物 |
| AR066405A1 (es) * | 2007-04-20 | 2009-08-19 | Glaxosmithkline Biolog Sa | Vacuna |
| RU2553325C2 (ru) | 2008-07-25 | 2015-06-10 | Институт Фо Ресёч Ин Биомедицин | Нейтрализующие антитела против вируса гриппа а и их использование |
| WO2010047509A2 (ko) | 2008-10-24 | 2010-04-29 | 아주대학교 산학협력단 | 친화도와 안정성이 향상된 항 ｄｒ5 항체, 및 이를 포함하는 암 예방 또는 치료용 조성물 |
| EA024262B1 (ru) * | 2008-11-25 | 2016-09-30 | Нанотерапьютикс Инк. | СПОСОБ ПОЛУЧЕНИЯ ВЫСОКОИНФЕКЦИОННОГО ВИРУСА ГРИППА, СТАБИЛЬНОГО ПРИ НИЗКИХ pH |
| CN101524538A (zh) | 2009-03-26 | 2009-09-09 | 成都康华生物制品有限公司 | 一种流感-大流行流感二价联合疫苗及其制备方法 |
| CA2790380A1 (en) | 2010-02-18 | 2011-08-25 | Mount Sinai School Of Medicine | Vaccines for use in the prophylaxis and treatment of influenza virus disease |
| EP2545074A4 (en) | 2010-03-08 | 2014-01-08 | Celltrion Inc | HUMAN MONOCLONAL ANTIBODIES MADE FROM HUMAN B-CELLS WITH NEUTRALIZING EFFECT AGAINST INFLUENZA A-VIRUS |
| MX2012011300A (es) | 2010-03-30 | 2012-11-29 | Sinai School Medicine | Vacunas del virus de influenza y usos de las mismas. |
| EP2699586B1 (en) | 2011-04-21 | 2019-03-06 | Ology Bioservices, Inc. | Methods for isolating and quantifying antigen from vaccines |
| CN102406931B (zh) * | 2011-11-25 | 2014-02-05 | 成都康华生物制品有限公司 | 大流行流感病毒裂解疫苗 |
| CN104302317B (zh) * | 2012-05-16 | 2016-07-06 | Kj生物科学有限公司 | 新型和改进的流感疫苗 |
| KR20140118682A (ko) | 2013-03-29 | 2014-10-08 | (주)셀트리온 | 2 이상의 인플루엔자 ａ 바이러스 중화 결합 분자를 포함하는 조성물 |
| US10124056B2 (en) | 2014-08-18 | 2018-11-13 | Sanofi Pasteur Inc. | Alkylated influenza vaccines |
| WO2016109792A2 (en) | 2014-12-31 | 2016-07-07 | The Usa, As Represented By The Secretary, Detp. Of Health And Human Services | Novel multivalent nanoparticle-based vaccines |
| US20180179256A1 (en) * | 2015-05-04 | 2018-06-28 | Epivax, Inc. | Modified H7 Hemagglutinin Glycoprotein of the Influenza A/Shanghai/2/2013 H7 Sequence |
| DK3355933T3 (da) * | 2015-09-29 | 2020-07-20 | Sumitomo Dainippon Pharma Co Ltd | Adeninkonjugatforbindelser og deres anvendelse som vaccineadjuvanser |
| FI3603619T3 (fi) * | 2017-03-29 | 2025-09-25 | Sumitomo Pharma Co Ltd | Rokoteadjuvanttiformulaatio |
| JP7403733B2 (ja) | 2017-09-04 | 2023-12-25 | 国立感染症研究所長 | インフルエンザｈａスプリットワクチンの製造方法 |
| IL280332B2 (en) * | 2018-07-23 | 2025-05-01 | Japan As Represented By Director General Of Nat Institute Of Infectious Diseases | A preparation containing influenza vaccine |
| CN113194986A (zh) * | 2018-12-26 | 2021-07-30 | 大日本住友制药株式会社 | 包括疫苗佐剂的制剂 |
| CN114025793A (zh) * | 2019-02-28 | 2022-02-08 | 诺瓦瓦克斯股份有限公司 | 用于预防由rsv感染引起的疾病或障碍的方法 |
-
2020
- 2020-03-03 JP JP2021504119A patent/JP7545955B2/ja active Active
- 2020-03-03 MY MYPI2021005035A patent/MY208974A/en unknown
- 2020-03-03 KR KR1020217030986A patent/KR20210135261A/ko active Pending
- 2020-03-03 EP EP20766488.9A patent/EP3936147A4/en active Pending
- 2020-03-03 PH PH1/2021/552094A patent/PH12021552094A1/en unknown
- 2020-03-03 BR BR112021017310A patent/BR112021017310A8/pt unknown
- 2020-03-03 EA EA202192398A patent/EA202192398A1/ru unknown
- 2020-03-03 SG SG11202109566X patent/SG11202109566XA/en unknown
- 2020-03-03 WO PCT/JP2020/008974 patent/WO2020179797A1/ja not_active Ceased
- 2020-03-03 CN CN202080033434.5A patent/CN114096273A/zh active Pending
- 2020-03-03 US US17/435,590 patent/US12491240B2/en active Active
- 2020-03-03 MX MX2021010685A patent/MX2021010685A/es unknown
- 2020-03-03 AU AU2020233456A patent/AU2020233456A1/en active Pending
- 2020-03-03 CA CA3132578A patent/CA3132578A1/en active Pending
-
2021
- 2021-08-31 IL IL285984A patent/IL285984A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2020179797A5 (enExample) | ||
| Lu et al. | Passive immunotherapy for influenza A H5N1 virus infection with equine hyperimmune globulin F (ab') 2 in mice | |
| Thérien et al. | A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling | |
| NZ511918A (en) | Flu vaccine comprising four synthetic peptide epitopes | |
| JP2009225809A5 (enExample) | ||
| JP2014500013A5 (enExample) | ||
| Ravin et al. | Plant-produced recombinant influenza vaccine based on virus-like HBc particles carrying an extracellular domain of M2 protein | |
| US10912825B2 (en) | Influenza vaccines | |
| CA3010049A1 (en) | Vaccine containing immobilized virus particles | |
| US11732031B2 (en) | Method for producing influenza HA split vaccine | |
| JP7545955B2 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JPS62175426A (ja) | 抗体及びこれを有効成分とするスプレ−剤 | |
| JP2019043937A5 (enExample) | ||
| CN115768799A (zh) | 抗her2单克隆抗体冻干制剂及制备方法 | |
| JPWO2008044611A1 (ja) | Ｉｐｖ−ｄｐｔワクチン | |
| WO2000020565A1 (en) | Enhanced immunogen for inactivated vaccine for infection with japanese encephalitis viruses and process for producing the same | |
| CN116410899A (zh) | 利用裂解酶LysP53产生细菌外膜囊泡的方法及应用 | |
| JPWO2016010081A1 (ja) | ウイルス様粒子を含むワクチン | |
| CN110746504A (zh) | 抗牛支原体MbovP579蛋白的单克隆抗体及其应用 | |
| CN112877300A (zh) | 一种g4型欧亚类禽h1n1猪流感病毒灭活疫苗的制备 | |
| US11633469B2 (en) | Reassortant influenza virus production method | |
| CN119751663B (zh) | 一种抗流感病毒np蛋白中和纳米抗体及其应用 | |
| CN1136010C (zh) | 亚单位抗原微乳剂疫苗的制造方法 | |
| WO2019045090A1 (ja) | インフルエンザｈａスプリットワクチンの製造方法 | |
| JPH02242673A (ja) | 新規な豚コレラ弱毒ウイルス株、その作出法並びに豚コレラ生ワクチン及その製造法 |